The Initial Public Offer of Global Health Limited is all set to list on the bourses on Wednesday, November 16, 2022. The price band for IPO has been fixed at Rs 319-336 per share. The company aims to raise Rs 2,206 crore from the issue. This includes fresh issue of Rs 500 crore and Rs 1,705 crore of an offer from sale. According to the subscription data from BSE, the IPO was subscribed 9 times for its 4.67 crore shares on the last day of subscription.
The proceeds from the public issue will be used to repayment or pre-payment of debts and for other corporate purposes.
Ahead of the public issue, Global Health limited has raised Rs 662 crore from anchor investors at Rs 336 a peice against 1.97 crore equity shares. Government of Singapore, Nomura, Axis Mutual Fund (MF), HDFC MF, Aditya Birla Sun Life MF, SBI MF, ICICI Prudential MF, Kotak MF, Max Life Insurance Company and SBI Life Insurance Company are among the anchor investors.
Global Health is the leading private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.